{"id":3713,"date":"2025-11-20T11:41:41","date_gmt":"2025-11-20T02:41:41","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/?page_id=3713"},"modified":"2026-02-19T10:10:04","modified_gmt":"2026-02-19T01:10:04","slug":"sarcoma-and-rare-cancers","status":"publish","type":"page","link":"https:\/\/atlas.ncc.go.jp\/en\/governance\/ATLAS-Study-Group\/sarcoma-and-rare-cancers\/","title":{"rendered":"Sarcoma and Rare Cancer Group"},"content":{"rendered":"

Description<\/b><\/h2>\r\n

ATLAS Sarcoma & Rare Cancer Group (SRCG) is a collaborative network dedicated to addressing Asia-specific unmet needs in sarcoma and rare cancers through practical international clinical research. In Asia, rare cancers are individually uncommon yet collectively represent a substantial proportion of cancer patients, and regional research support has been limited. SRCG bridges this gap by combining consensus-building across countries, platform-based cohorts (including MASTER KEY Asia), and investigator-initiated interventional studies, while proactively strengthening collaboration with leading international cooperative groups in other regions. By leveraging sarcoma as a starting point, SRCG also aims to establish scalable approaches that can be extended to other rare cancer types and improve equitable, high-quality care across the region.<\/span><\/p>\r\n

Members<\/h2>\r\n\r\n\r\n\r\n\r\n
\"\"<\/td>\r\n\"\u5927\u718a\u3000\u3072\u3068\u307f\u306e\u5199\u771f\"<\/td>\r\n<\/tr>\r\n
\r\n

Chair<\/b>
\r\nDr. Tom Wei-Wu Chen
\r\nNational Taiwan University Hospital,
\r\nTaiwan<\/p>\r\n<\/td>\r\n

\r\n

Secretary
\r\n<\/b>Dr. Hitomi Okuma
\r\nNational Cancer Center Hospital,
\r\nJapan<\/p>\r\n<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","protected":false},"excerpt":{"rendered":"Description ATLAS Sarcoma & Rare Cancer Group (SRCG) is a collaborative network dedicated to addressing Asia-specific unmet needs in sarcoma and rare cancers through practical international clinical research. In Asia, rare cancers are individually uncommon yet collectively represent a substantial proportion of cancer patients, and regional research support has been limited. SRCG bridges this gap […]","protected":false},"author":23,"featured_media":0,"parent":4012,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/atlas.ncc.go.jp\/?page_id=3693","footnotes":""},"class_list":["post-3713","page","type-page","status-publish","hentry","en-US"],"acf":{"page_preface":"ATLAS Sarcoma & Rare Cancer Group (SRCG) is a collaborative network dedicated to addressing Asia-specific unmet needs in sarcoma and rare cancers through practical international clinical research. "},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/comments?post=3713"}],"version-history":[{"count":10,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3713\/revisions"}],"predecessor-version":[{"id":4021,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3713\/revisions\/4021"}],"up":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/4012"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}